Mindfulness Training for Children With Attention-Deficit/Hyperactivity Disorder (ADHD) and Mindful Parenting
MindChamp
1 other identifier
interventional
103
1 country
3
Brief Summary
This study evaluates the effectiveness of an 8-week mindfulness group training for children (8-16 years old) with ADHD in combination with a parallel mindful parenting training for their parents. Half of the participants will be randomly assigned to the mindfulness training in addition to care-as-usual (CAU); the other half to CAU-only. The hypothesis is that compared to care-as-usual only, the addition of the mindfulness training will improve self-control of youth with ADHD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2016
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 18, 2016
CompletedFirst Submitted
Initial submission to the registry
June 20, 2017
CompletedFirst Posted
Study publicly available on registry
July 18, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
February 22, 2019
CompletedMarch 7, 2019
March 1, 2019
2.4 years
June 20, 2017
March 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Baseline in parent-rated self-control of the child
Behaviour Rating Inventory of Executive Function, parent-report (BRIEF-P)
Baseline, 3, 5 and 9 months
Secondary Outcomes (22)
Change from Baseline in parent-rated behaviour problems of the child
Baseline, 3, 5 and 9 months
Change from Baseline in parent-rated autistic social impairment of the child
Baseline, 3 and 9 months
Change from Baseline in parent-rated quality of life of the child
Baseline, 3 and 9 months
Change from Baseline in teacher-rated self-control of the child
Baseline, 3 and 5 months
Change from Baseline in teacher-rated behaviour problems of the child
Baseline, 3 and 5 months
- +17 more secondary outcomes
Study Arms (2)
Care-as-usual (CAU) only
OTHERCare-as-usual for children (8-16 years old) with ADHD
Mindfulness for child and parent + CAU
EXPERIMENTALMYmind mindfulness training in addition to care-as-usual for children aged 8-16 years with ADHD
Interventions
The MYmind mindfulness training uses a standardised protocol based on mindfulness-based cognitive therapy. It consists of 8 weekly group sessions of 90 minutes for youth with ADHD, and parallel mindful parenting training for the parents. Eight weeks after the last session there is a single 90 minutes booster session.
According to the Dutch Multidisciplinary guidelines for the diagnosis and treatment of ADHD, care-as-usual for children aged 8-16 years with ADHD consists of psycho-education and the prescription of medication approved for ADHD and/or evidence-based parent and/or teacher-administered behaviour therapy, preferably both medication and behaviour therapy. First-line option for medication is a psychostimulant, second-line option is atomoxetine, and third-line options are alpha-2 presynaptic agonists or tricyclic antidepressants (imipramine).
Eligibility Criteria
You may qualify if:
- Child has a clinical diagnosis of ADHD according to the Diagnostic and Statistical Manual of Mental Disorders; DSM-IV or DSM-5 system, and confirmed by a structured interview (The Schedule for Affective Disorders and Schizophrenia for school-Age Children (K-SADS)).
- Child receives CAU and has remaining ADHD-symptoms (average score \> 1.0 on the investigator-rated DSM-5 items from the Conners' ADHD rating scale).
- Child is between 8 and 16 years old.
- At least one parent is willing to participate.
- ADHD medication dose is stable, or there is an informed decision on not taking ADHD medication.
- Psychiatric comorbidities are allowed except psychosis, bipolar illness, active suicidality, untreated posttraumatic stress disorder or substance use, provided ADHD is the primary diagnosis in the child; similarly, psychopathology in the parents is allowed except psychosis, bipolar disorder, active suicidality, untreated posttraumatic stress disorder or substance use.
- Child and parent have an estimated intelligence quotient (IQ) ≥ 80.
- Child and parent have adequate mastery of Dutch language.
You may not qualify if:
- Child or the participating parent(s) have participated in a mindfulness programme in the past year or ever in a Mindful Parenting training.
- Child or parent is participating in another intervention study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karakter Kinder- en Jeugdpsychiatrielead
- Fonds Psychische Gezondheidcollaborator
- European Commissioncollaborator
- UvA mindscollaborator
- Radboud University Medical Centercollaborator
- University of Amsterdamcollaborator
Study Sites (3)
Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Arnhem, Gelderland, 6812DE, Netherlands
Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Ede, Gelderland, 6717LX, Netherlands
Karakter, Expertisecentrum voor kinder- en jeugdpsychiatrie
Nijmegen, Gelderland, 6525GC, Netherlands
Related Publications (1)
Siebelink NM, Bogels SM, Boerboom LM, de Waal N, Buitelaar JK, Speckens AE, Greven CU. Mindfulness for children with ADHD and Mindful Parenting (MindChamp): Protocol of a randomised controlled trial comparing a family Mindfulness-Based Intervention as an add-on to care-as-usual with care-as-usual only. BMC Psychiatry. 2018 Jul 25;18(1):237. doi: 10.1186/s12888-018-1811-y.
PMID: 30045714BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan K Buitelaar
Karakter Kinder- en Jeugdpsychiatrie
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 20, 2017
First Posted
July 18, 2017
Study Start
February 18, 2016
Primary Completion
July 26, 2018
Study Completion
February 22, 2019
Last Updated
March 7, 2019
Record last verified: 2019-03
Data Sharing
- IPD Sharing
- Will share
Data will be available 18 months after finishing the study. The investigators will give limited access to the data, that is, data can be obtained provided that the applicant will submit a research plan and the investigator of the current study will be involved in the research on the shared data. Data will be anonymised and accompanied by the present study protocol and data list description. Other researchers can contact Karakter (sponsor of the study) to obtain data: Address: Reinier Postlaan 12 6525 GC Nijmegen Phone: 024 351 22 22 Email: info.nijmegen@karakter.com